Project Grant R61HL171110
Award Date
9/1/24
Completion Date
8/31/25
Dollars Obligated
$2M
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), is funding a randomized controlled trial to evaluate the effectiveness of gamification and social incentives in increasing adherence to physical activity recommendations among patients with heart failure with preserved ejection fraction (HFPEF). The 5-year, $809,029 award will support a 3-arm trial to assess whether interventions using...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $797,130 to The Children's Hospital of Philadelphia (CHOP) from September 2024 to June 2028. The project aims to implement and evaluate the real-world effectiveness of "single maintenance and reliever therapy" (SMART) for managing moderate-to-severe childhood asthma in a predominantly Black pediatric population. The study uses a...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) will support a $691,299 hybrid effectiveness-implementation trial to evaluate the impact of provider referrals to a remotely delivered physical activity intervention for Latina adolescents. The intervention, called "Chicas Fuertes 2," will leverage mobile technologies like wearable trackers, personalized text messages, and social media to promote...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) will provide $374,592 to the University of Rochester to support Dr. Lachant's research on an electronically-delivered rehabilitation program for patients hospitalized with acute pulmonary embolism. The goal is to evaluate whether a prescriptive exercise program can reduce post-pulmonary embolism syndrome by addressing deconditioning and anxiety. The study will...
This federal Project Grant award of $792,235 from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports the development and execution of a randomized clinical trial to evaluate the effectiveness of a commercially available fitness mHealth app (Rehabbing with Peloton) for improving physical activity among individuals recovering from transcatheter aortic valve replacement (TAVR). The key products and services to be delivered under this grant include:...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under CFDA Program 93.837 - Cardiovascular Diseases Research, provides $180,174 to The Children's Hospital of Philadelphia (CHOP) to develop a framework for designing the next generation of pediatric acute respiratory distress syndrome (ARDS) clinical trials. The key objectives of this 5-year project are to: 1) compare heterogeneity of treatment effect analysis methodologies in a pediatric ARDS...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $452,181 to develop and test an 8-week exercise-based frailty intervention called XFIT for lung transplant candidates. The goal is to improve physical function and reduce frailty in this population at high risk for disability and mortality. The award includes sub-grants to Columbia University ($352,181) and the University of Pennsylvania ($100,000) to serve as study...
This $2,130,422 Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will fund a comprehensive evaluation of lean muscle mass in patients with pulmonary arterial hypertension (PAH). The research aims to: 1) characterize the endophenotype and metabolomic signature of PAH patients with low lean mass, 2) understand the role of epicardial adipose tissue, 3) assess the impact of low lean mass on patient...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) is focused on testing the effectiveness and implementation of a home-based exercise intervention for individuals with an implantable cardioverter defibrillator (ICD). The primary goal is to determine if the Exercise-ICD (E-ICD) intervention can increase physical activity and improve related health outcomes in this patient population. The $728,781 award to the...
This National Heart, Lung, and Blood Institute (NHLBI) Project Grant award under CFDA 93.837 Cardiovascular Diseases Research provides $1,044,896 to 3-C Institute For Social Development Inc. (doing business as 3C Institute), a woman-owned small business, to develop a comprehensive digital platform called FBT 2.0. The FBT 2.0 platform will deliver an integrated suite of intervention components for family-based behavioral treatment (FBT) of childhood obesity, including personalized self-paced...